Characterization of salivary gland tumours with diffusion tensor imaging

To characterize salivary glands tumours with diffusion tensor imaging.

This study was conducted upon 53 patients (aged 18-81 years: mean 37 years) with salivary gland tumours that underwent diffusion tensor imaging was obtained using a single-shot echoplanar imaging sequence with parallel imaging at 1.5 T scanner. 48 slices were obtained, with a thickness of 2.5 mm, with no gap and the total scan duration was 7-8 min. The fractional anisotropy (FA) and the mean diffusivity (MD) value of the salivary gland tumours was calculated and correlated with pathological findings. Image analysis was performed by one radiologist. The receiver operating characteristic curve was drawn to detect the cut-off point of FA and MD used to characterize salivary gland tumours.

The mean FA and MD of malignant salivary gland tumours (n = 17) (0.41 ± 0.07 and 0.89 ± 0.15 × 10^-3 mm² s^-1) was significantly different (p = 0.001) than that of benign tumours (n = 36) (0.19 ± 0.07 and 1.28 ± 0.42 × 10^-3 mm² s^-1), respectively. Combined FA and MD used to differentiate malignant from benign tumours has an area under the curve (AUC) of 0.974, and an accuracy of 86%. There was a significant difference in FA between Warthin tumours and malignant tumours (p = 0.001). Selection FA of 0.35 to differentiate malignant tumours from Warthin tumours revealed AUC of 0.878 and an accuracy of 80%. There was a significant difference in FA and MD of malignant tumours and pleomorphic adenomas (p = 0.001). Combined FA and MD used to differentiate malignant tumours from pleomorphic adenomas revealed AUC of 0.993, and an accuracy of 93%. There was a significant difference in FA and MD of Warthin tumours and pleomorphic adenomas (p = 0.001). Combined FA and MD used to differentiate Warthin tumours from pleomorphic adenomas revealed AUC of 0.978, and an accuracy of 86%.

Diffusion-weighed imaging is a promising non-invasive method and it may be useful for the characterization and differentiation of benign and malignant salivary gland tumours.